companydata.dkENDOGEN ApS: Financial statements 2016
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 0 and a net result of DKK -13,532 compared with DKK -16,471 the year before. Equity amounted to DKK 42,590. The solvency ratio was 100%.
- Revenue
- 0 kr.
- Gross Profit
- -13,184 kr.
- Profit/Loss
- -13,532 kr.
- Equity
- 42,590 kr.
- Total Assets
- 42,590 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 0 | -13 t. | -14 t. | 43 t. | - |
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
| 2012 | 0 | -990 | -1 t. | 121 t. | - |
How creditworthy is ENDOGEN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
ENDOGEN ApS has published its annual report for 2015. Revenue came to DKK 18,574, and the net result was DKK -16,471.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.